Preoperative Weight Gain Is Not Related to Lower Postoperative Weight Loss, But to Lower Total Weight Loss up to 3 Years After Bariatric-Metabolic Surgery
verfasst von:
Anne Jacobs, May Al Nawas, Laura N. Deden, Lea M. Dijksman, Evert-Jan G. Boerma, Ahmet Demirkiran, Eric J. Hazebroek, M. (René) J. Wiezer, Wouter J.M. Derksen, Valerie M. Monpellier
Weight loss prior to bariatric-metabolic surgery (BMS) is recommended in most bariatric centers. However, there is limited high-quality evidence to support mandatory preoperative weight loss. In this study, we will evaluate whether weight gain prior to primary BMS is related to lower postoperative weight loss.
Methods
A retrospective analysis of prospectively collected data was performed. Preoperative weight loss (weight loss from start of program to day of surgery), postoperative weight loss (weight loss from day of surgery to follow-up), and total weight loss (weight loss from start of program to follow-up) were calculated. Five groups were defined based on patients’ preoperative weight change: preoperative weight loss of >5 kg (group I), 3–5 kg (group II), 1–3 kg (group III), preoperative stable weight (group IV), and preoperative weight gain >1 kg (group V). Linear mixed models were used to compare the postoperative weight loss between group V and the other four groups (I–IV).
Results
A total of 1928 patients were included. Mean age was 44 years, 78.6% were female, and preoperative BMI was 43.7 kg/m2. Analysis showed significantly higher postoperative weight loss in group V, compared to all other groups at 12, 24, and 36 months follow-up. Up to three years follow-up, highest total weight loss was observed in group I.
Conclusion
Weight gain before surgery should not be a reason to withhold a bariatric-metabolic operation. However, patients with higher preoperative weight loss have higher total weight loss. Therefore, preoperative weight loss should be encouraged prior to bariatric surgery.
A. Jacobs and M. Al Nawas have contributed equally to this work.
Key Points
- Weight loss before bariatric-metabolic surgery (BMS) improves total weight loss.
- Higher preoperative weight loss gives patients a “head start” before surgery.
- Weight gain vs. weight loss before BMS does not lead to lower postop weight loss.
- Preoperative weight gain should not be a reason to decline people to undergo BMS.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Introduction
Bariatric-metabolic surgery (BMS) is the most effective treatment for severe obesity. It results in significant weight loss and resolution of obesity-related medical problems [1, 2]. To improve post-bariatric outcomes, some advocate (mandatory) preoperative weight loss. Furthermore, many insurance companies require adherence to a preoperative weight loss program or a specific amount of weight loss as a prerequisite for approval for BMS [3, 4]. However, it is unclear whether preoperative weight loss is related to postoperative weight loss after BMS and if patients with weight gain prior to surgery have lower postoperative weight loss.
Preoperative weight loss has been hypothesized to be a marker to identify patients who are compliant to the treatment program [3]. Patients who achieve weight loss before surgery are believed to be more motivated and adapted to the new postoperative lifestyle and, thus, more successful in reaching and sustaining satisfactory postoperative weight loss [5‐9].
Anzeige
Since the concept of preoperative weight loss was first introduced by the National Institutes of Health consensus panels in the 1990s, studies have reported conflicting and inconsistent results on the effects of preoperative weight loss on post-bariatric weight loss [8‐13]. The most important reason for this is that the definition of preoperative weight loss is often unclear and differs between studies [14‐19]. Preoperative weight loss is often included in the calculation of total postoperative weight loss, making it impossible to study the exact relationship between preoperative weight loss and postoperative weight loss [20‐22]. Moreover, there is heterogeneity of the study designs, and often a relatively small number of patients are included [3, 8‐13]. Lastly, most studies focus only on short term weight loss (12 months follow-up point) [6‐8, 10]. Hence, there is limited high-quality evidence to support or refute mandatory preoperative weight loss for patients who will undergo BMS.
In this study, we analyze data of a large multicenter cohort with prospectively collected data up to 3 years after surgery. We aim to evaluate whether weight gain prior to primary BMS is related to lower postoperative weight loss.
Methods
Study Design
A retrospective analysis of prospectively collected data was performed to evaluate the effect of preoperative weight loss in patients undergoing elective BMS. This study was approved by the Medical Ethical Committee Zuyderland & Zuyd (METCZ20190097) and the Local Ethics Committees in the participating bariatric centers. The study was reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies [23].
Setting
The cohort consisted of patients who underwent primary BMS between January 1st and December 31st of 2017 in one of the following hospitals, all located in the Netherlands: St. Antonius hospital Nieuwegein, Rijnstate hospital Arnhem, Rode Kruis hospital Beverwijk, and Zuyderland Medical Center Heerlen. All patients followed a pre- and postoperative interdisciplinary program at the Nederlandse Obesitas Kliniek (Dutch Obesity Clinic, NOK). The NOK is the largest outpatient clinic center in the Netherlands for the treatment of obesity. At the NOK care centers, patients follow an interdisciplinary treatment program [24]. The preoperative program consists of six group sessions spread over 6 weeks, where all patients were advised to aim for a weight loss of 3–5 kg. The postoperative program included a comprehensive 1-year lifestyle change program. Postoperative follow-up visits are attended yearly until 5 years after surgery.
Anzeige
Patient Population
All patients were screened according to International Federation for the Surgery of Obesity criteria [25] and underwent one of the following primary laparoscopic BMS procedures: Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or banded Roux-en-Y gastric bypass (bRYGB). Patients with a medical history of BMS and patients who took part in an individual treatment program (e.g., because of linguistic barriers or psychopathology) were excluded. Cases missing weight data at the start of the preoperative care program or at the day of surgery were also excluded.
Data Source
Patients were included from the database of the NOK. Data was collected from the NOK patient files, the hospital patient files, and was linked to the Dutch national registry Dutch Audit of Treatment of Obesity (DATO). The DATO is a mandatory registry containing patients’ data from all hospitals performing BMS in the Netherlands since January 2015 [26].
Variables
Data was collected until January 2021. Study data collected from the NOK database include patient demographics (age and gender), surgical procedure, preoperative obesity-associated medical problems (diabetes mellitus, hyperlipidemia, hypertension, and obstructive sleep apnea), and the weight measured at the clinic at the start of the preoperative care program as well as at follow-up appointments up to 3 years after surgery (3, 6, 12, 18, 24, and 36 months).
The preoperative American Society of Anesthesiologists (ASA) physical status classification, weight measured in the hospital at the day of surgery, perioperative complications, and severe short-term <30-day postoperative complications according to the Clavien-Dindo Classification of Surgical Complications grade ≥III [27] were collected from the hospital patient files and DATO database.
Preoperative Weight Change
Preoperative weight change (PWC) was defined as the difference in kilograms between the weight at the start of the preoperative care program (first group session) and the weight measured at the day of the bariatric procedure:
Based on their PWC, patients were stratified into five groups: those who lost >5 kg (group I), those who lost 3–5 kg (group II), those who lost 1–3 kg (group III), those who had a stable weight with a range of 1 kg (group IV), and those who gained more than 1 kg (group V). These cut-offs were believed to be clinically relevant, since patients are advised to not gain weight and to lose 3–5 kg. This results in five groups with an equal range of 2 kg between the groups.
Outcome Measures
Weight loss was calculated as percentage total weight loss (%TWL) and absolute change in body mass index (ΔBMI). Figure 1 provides an overview of the used definitions of weight loss.
Fig. 1
Overview of the used definitions of weight loss
×
Postoperative TWL was defined as the percentage of weight difference between the weight at the day of surgery and follow-up weight:
Descriptive statistics were used to summarize baseline characteristics. Categorical data were expressed as number (percentages). Continuous data were expressed as mean ± standard deviation when normally distributed, otherwise as median [interquartile range]. Baseline differences between the PWC groups were evaluated by using analysis of variance (ANOVA) for continuous variables and chi-square tests for categorical variables.
Linear mixed model analysis was used to compare the change in postTWL over time in the five groups. The groups were included as covariates in the fixed part, where group V (> 1 kg weight gained) was used as reference group. After determining the best-fitting model with random intercept and/or slope, only a random intercept for subject (patient) was added in the crude model (model 1). Age at baseline, sex, BMI at start of the preoperative care program, and (natural logarithm of) time between start preoperative care program and day of surgery were considered as important confounders and were included as covariates in model 2. Model 3 included the following additional confounders: preoperative ASA score, number of associated medical problems at baseline, type of BMS, and the bariatric center where the patients were treated. The results of the models for 12, 24, and 36 months postTWL were reported as (adjusted) regression coefficients (β) with 95% confidence interval (95% confidence intervals, CI) and the p-value.
Anzeige
Statistical analysis was performed using SPSS (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp). Weight changes were presented in graphs, created by using the package “ggplot2” in R (R Foundation for Statisical Computing, Vienna, Austria. URL https://www.R-project.org). All statistical tests were two-tailed, and p<.05 was considered statistically significant.
Results
Study Population
A total of 1945 patients underwent primary BMS in one of the participating bariatric centers in 2017 and followed a perioperative care program at the NOK. Seventeen patients (0.9%) were excluded due to missing weight data at the start of the treatment program and/or the day of surgery. A total of 1928 patients were included.
Baseline Characteristics
The majority of patients was female (78.6%) and mean age was 44.1±11.4 years (Table 1). Median time interval between the start of the preoperative care program and BMS was 7.3 weeks [6.1–9.1]. The most frequently performed BMS was RYGB (n=1229, 63.7%), followed by SG (n=446, 23.1%), and bRYGB (n=253, 13.1%). A total of 34 (1.7%) patients had a perioperative (n=10, 0.5%) or severe short-term (n=24, 1.2%) complication within 30 days after surgery. There was no mortality in this cohort.
Table 1
Demographic characteristics of the total population (n=1928) presented as mean ± standard deviation or number (percentage)
Variable
Value
Age, years
44.1 ± 11.4
Female sex
1517 (78.6)
Bariatric surgery type
Roux-en-Y gastric bypass
1229 (63.7)
Sleeve gastrectomy
446 (23.1)
Banded Roux-en-Y gastric bypass
253 (13.1)
ASA score
2
1040 (53.9)
3
866 (44.9)
4
15 (0.8)
Associated medical problems
Hypertension
663 (34.4)
Type 2 diabetes
394 (20.4)
Dyslipidemia
383 (19.9)
Obstructive sleep apnea syndrome
338 (17.5)
BMI, kg/m2
Start of preoperative care program
43.7 (±5.6)
Day of surgery
43.1 (±5.6)
ASA American Society of Anesthesiologists physical status classification, BMI body mass index
Comparison Between Groups
In total, 296 patients were included in group I, 263 in group II, 447 in group III, 623 in group IV, and 299 in group V. An overview of all characteristics is shown in Table 2. The groups were comparable for most characteristics, though some differences were observed. Age was lower in group V compared to all other groups (p=.02). In group I and II, the percentage of people undergoing a banded RYGB was higher compared to the other groups (p<0.01). The frequency of type II diabetes was higher in group II and IV as compared to the other groups (p<0.01).
Table 2
Comparison of the groups according to preoperative weight change before bariatric surgery presented as mean ± standard deviation, median interquartile range, or number (percentage)
Group I
Weight loss
(>5 kg)
Group II
Weight loss
(3–5 kg)
Group III
Weight loss
(1–3 kg)
Group IV
Stable weight
(−1 to +1 kg)
Group V
Weight gain
(>1 kg)
p-value
Number of patients
296
263
447
623
299
Age, years
44.8 ± 10.4
45.0 ± 11.4
44.9 ± 11.1
43.6 ± 11.8
42.6 ± 12.0
0.02
Female
222 (75.0)
205 (77.9)
370 (82.8)
496 (79.6)
224 (74.9)
0.04*
Bariatric surgery type
<0.01*
Roux-en-Y gastric bypass
141 (47.6)
158 (60.1)
314 (70.2)
437 (70.1)
179 (59.9)
Sleeve gastrectomy
38 (12.8)
59 (17.5)
96 (21.5)
152 (24.4)
101 (33.8)
Banded Roux-en-Y gastric bypass
117 (39.5)
46 (22.4)
37 (8.3)
34 (5.5)
19 (6.4)
ASA score
<0.01*
2
142 (48.0)
110 (41.8)
250 (55.9)
373 (55.9)
165 (55.2)
3
147 (49.7)
151 (47.4)
193 (43.2)
242 (38.8)
133 (44.5)
4
7 (2.7)
1 (0.4)
2 (0.4)
4 (0.6)
1 (0.3)
Associated medical problems
Hypertension
99 (33.4)
96 (36.5)
154 (34.5)
215 (34.5)
99 (33.1)
0.93
Type 2 diabetes
46 (15.5)
60 (22.8)
95 (21.3)
143 (23.0)
50 (16.7)
0.03*
Dyslipidemia
60 (20.3)
56 (21.3)
93 (20.8)
116 (18.6)
58 (19.4)
0.87
OSAS
58 (19.6)
52 (19.8)
80 (17.9)
96 (15.4)
52 (17.4)
0.44
BMI, kg/m2
Start preoperative care program
44.6 ± 6.8
43.9 ± 5.5
43.2 ± 5.1
43.5 ± 5.2
44.0 ± 5.6
0.01*
Day of surgery
42.0 ± 6.6
42.5 ± 5.5
42.5 ± 5.1
43.5 ± 5.2
45.0 ± 5.7
<0.01*
Preoperative weight change
Weight change before surgery, kg
−6.8 [−5.9 to −8.5]
-4.0 ± 0.6
−2.0 ± 0.6
0.0 ± 0.6
2.2 [1.5–3.7]
<0.01*
Weight change before surgery, %TWL
−5.8 [−5.0 to −7.2]
−3.3 ± 0.7
−1.6 ± 0.5
0.0 ± 0.5
1.7 [1.2–2.8]
<0.01*
ASA American Society of Anesthesiologists physical status classification, OSAS obstructive sleep apnea syndrome, BMI body mass index, TWL total weight loss. *Significant differences between groups
Anzeige
Weight and Preoperative Weight Change
The mean BMI at the start of the preoperative care program was 43.7±5.6 kg/m2 and BMI at the day of surgery was 43.1±5.6 kg/m2 (Table 1). In group I, BMI at the start of the preoperative care program was higher as compared to group III and group IV (44.6±6.8 versus 43.2±5.1 and 43.5±5.2 kg/m2, respectively (Table 2, p=.01).
In the total population, mean preoperative weight change was −1.7±3.4 kg. In group I, median weight loss was −6.8kg [−5.9 to −8.5], and group V gained median +2.2 kg [1.5 to 3.7] between the start of the preoperative care program and the day of surgery.
Total Weight Loss
The weight change of the total bariatric program from the start of the preoperative care program until 3 years after BMS is presented in Figs. 2 (%TWL) and 3 (BMI) and Supplementary Table 1. The weight loss pattern was similar in all five groups, with a largest weight loss achieved at 18-month follow-up. At 3-year follow-up, mean totalTWL was 33.7±8.2 %, 32.6±8.6%, 31.7±8.7%, 31.1±8.8 %, and 32.1±8.5 % for the groups I, II, III, IV, and V, respectively. Mean ΔBMI was also highest in group I, −15.1±4.9 compared to −14.3±4.6, −13.8±4.4, −13.4±4.2, and −14.3±4.4 for, respectively, group II, III, IV, and V. Loss to follow-up was 30.5% at 3-year follow-up (Supplementary Table 1).
Fig. 2
Preoperative weight change and postoperative total weight loss over time for each of the study groups
Fig. 3
Body mass index over time for each of the study groups
×
×
Postoperative Weight Loss
Highest postTWL at 3-year follow-up was observed in group V (33.5±8.3%) compared to group I (29.6±8.8), group II (30.4±9.0), group III (30.6±8.9), and group IV 31.1±8.8 (Fig. 2 and Supplementary Table 1). Adjusted for potential confounders, group V had a significant higher postTWL at 12-, 24-, and 36-month follow-up, compared to all other groups (p<0.01, Table 3). For example, adjusted for all potential confounders, BMS lead to a 4.03% lower postTWL in group I (lost >5 kg) compared to group V (gain > 1 kg) (β −4.03; 95% CI −5.21 to −2.85, p<0.01) (Table 3).
Table 3
Mixed models analysis for the percentage postoperative total weight loss (postTWL), group V (weight gain >1 kg) is the reference group
12 months
24 months
36 months
β
95% CI
p-value
β
95% CI
P-value
β
95% CI
p-value
Group I
Weight loss >5 kg
Model 1a
−2.42
−3.55 to −1.30
<0.01
−3.05
−4.20 to −1.89
<0.01
−3.71
−4.91 to −2.52
<0.01
Model 2b
−2.76
−3.86 to −1.67
<0.01
−3.39
−4.51 to −2.27
<0.01
−4.07
−5.23 to −2.91
<0.01
Model 3c
−2.76
−3.87 to −1.64
<0.01
−3.36
−4.50 to −2.22
<0.01
−4.03
−5.21 to −2.85
<0.01
Group II
Weight loss 3–5 kg
Model 1a
−1.68
−2.84 to −0.52
0.01
−2.92
−4.12 to −1.71
<0.01
−2.43
−3.67 to −1.19
<0.01
Model 2b
−1.96
−3.01 to −0.84
<0.01
−3.20
−4.37 to −2.03
<0.01
−2.72
−3.93 to −1.52
<0.01
Model 3c
−1.60
−2.70 to −0.49
0.01
−2.83
−3.99 to −1.68
<0.01
−2.35
−3.54 to −1.16
<0.01
Group III
Weight loss 1–3 kg
Model 1a
−1.07
−2.10 to −0.05
0.04
−1.44
−2.50 to −0.39
0.01
−2.09
−3.18 to −0.99
<0.01
Model 2b
−1.26
−2.25 to −0.26
0.01
−1.62
−2.65 to −0.60
<0.01
−2.27
−3.34 to −1.21
<0.01
Model 3c
−1.33
−2.29 to −0.37
0.01
−1.69
−2.68 to −0.69
<0.01
−2.32
−3.35 to −1.29
<0.01
Group IV
Stable weight
Model 1a
−0.94
−1.90–0.03
0.06
−1.69
−2.69 to −0.69
<0.01
−1.97
−3.01 to −0.94
<0.01
Model 2b
−0.92
−1.85–0.01
0.05
−1.66
−2.63 to −0.70
<0.01
−1.96
−2.96 to −0.96
<0.01
Model 3c
−1.00
−1.90 to −0.09
0.03
−1.73
−2.67 to −0.80
<0.01
−2.02
−3.00 to −1.05
<0.01
β = coefficient of regression, e.g., difference in % postTWL between group V (reference group) and the other groups; 95% CI 95% confidence interval
aCrude model. bModel adjusted for age, sex, preoperative BMI, time between start preoperative program and day of surgery. cModel adjusted for covariates in model 2 plus hospital, ASA score, comorbidities (0, 1, 2, 3, or 4 conditions), and type of bariatric surgery (RYGB, GS, bRYGB)
Discussion
In this large retrospective cohort study, the goal was to study if patients with weight gain prior to primary BMS had lower postoperative weight loss. Our data show that the highest postoperative weight loss was observed in the group with preoperative weight gain, with a difference at 36 months of 4.03% when compared to the group that had the highest preoperative weight loss. Therefore, preoperative weight gain should not be used as a negative “indicator” for postoperative weight loss and patients should not be denied BMS, solely based on their preoperative weight change. Total weight loss (combination of pre- and postoperative) was highest in the group of patients with the highest preoperative weight loss (maximum difference 2.5%). The higher total weight loss seems to be entirely attributed to the weight lost before surgery.
Previous (systematic) reviews and meta-analyses addressing this issue also concluded there was no evidence that weight loss prior to surgery improved weight loss [9, 10, 12, 13, 28]. Thus, the assumption that more preoperative weight loss indicates a greater level of motivation and leads to better weight loss after surgery appears to be unfounded. Our finding that higher total weight loss was observed in patients with the highest preoperative weight loss suggests that preoperative weight loss may give patients a “head start” in their weight loss journey. Therefore, preoperative weight loss should still be encouraged to all patients applying for BMS.
A key implication is that clear and accurate definitions of outcome measurements for weight loss are essential. In the current study, there were strict definitions of preoperative weight loss, postoperative weight loss, and total weight loss. Often, there are no clear definitions of preoperative and postoperative weight loss; the studies might have investigated total weight loss, instead of postoperative weight loss [20‐22].
The strength of the current study is its strict and specific definitions of preoperative weight loss, postoperative weight loss, and total weight loss and the large multicentre patient group with high follow-up rates at 36 months after surgery. A limitation of the current study is that the main outcomes were limited to weight loss. Preoperative weight loss may also affect other BMS outcomes, such as the risk of perioperative complications. Finally, due to the retrospective design, the current study does not provide information on which treatments or patient characteristics are associated with preoperative weight change.
Conclusion
Preoperative weight gain is not related to lower postoperative weight loss up to 3 years after BMS and should not be a reason to deny patients access to treatment. However, patients who lose weight before surgery have higher total weight loss, because of the weight lost before the procedure. Therefore, preoperative weight loss should be encouraged prior to bariatric surgery.
Declarations
Ethical Approval
This study was approved by the Medical Ethical Committee Zuyderland & Zuyd (METCZ20190097) and the Local Ethics Committees in the participating bariatric centers. For this type of study formal consent was not required.
Informed Consent
Informed consent does not apply.
Conflict of Interest
Authors A. Jacobs and V.M. Monpellier receive salary from the Nederlandse Obesitas Kliniek. Author E.G. Boerma is the medical director of NOK location Zuid. The other authors (M. Al Nawas, L.N. Deden, L.M. Dijksman, A. Demirkiran, E.J. Hazebroek, M.J. Wiezer and W.J.M. Derksen) declare that they have no conflict of interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.
Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!
Preoperative Weight Gain Is Not Related to Lower Postoperative Weight Loss, But to Lower Total Weight Loss up to 3 Years After Bariatric-Metabolic Surgery
verfasst von
Anne Jacobs May Al Nawas Laura N. Deden Lea M. Dijksman Evert-Jan G. Boerma Ahmet Demirkiran Eric J. Hazebroek M. (René) J. Wiezer Wouter J.M. Derksen Valerie M. Monpellier
Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.
Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.
Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.
Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
